My understanding is there will be interim results , the burns and general scaring is easily understood by the wider market the results are visually noticeable with the naked eye... One of my key investment strategies is that Dermal Treatments are in the lowest regulated category of the medical complexity matrix.
When you have the caliber of Principal Investigators and the head of Burns Australia joining in , you know there is something significant .. When you have Medical Practitioners buying stock , its a clear indication on what they believe the results will be.. NZT
I'm not one for crystal balls but SNT with 4 Phase II in play with cash in hand should be a winner from November onwards ...the run up to 5c demonstrates how quickly the game change ...
SNT Price at posting:
3.1¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)